Thyroid Follicular Cell Signaling and Development in Humans
Thyroid Follicular Cell Signaling and Development in Humans
批准号:
10801642
负责人:
ANTHONY N HOLLENBERG
金额:
$41.25万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-01 至 2025-04-30
关键词:
AdultAffectAnteriorAreaAttentionBMP4Biological AssayBirthBone Morphogenetic ProteinsCell LineCell LineageCell TherapyCell TransplantationCellsClone CellsComputer ModelsCretinismDNA Sequence AlterationDefectDerivation procedureDevelopmentDevelopmental BiologyEndodermEngineeringEnsureEpitheliumExperimental DesignsFGF2 geneFetal DevelopmentFibroblast Growth FactorFutureGenesGenetic ProcessesGoalsGrowth FactorHealthHeterozygoteHormone replacement therapyHormone secretionHumanHuman BiologyHypothyroidismImmunodeficient MouseImmunologic Deficiency SyndromesIn VitroIndividualLeadLifeLongevityMediatorMethodologyModelingMusMutationNatural regenerationOrganoidsPathway interactionsPatientsPluripotent Stem CellsPopulationPrimitive foregut structureProcessProductionQuantitative EvaluationsRanaRegenerative capacityReporterResolutionRoleSafetySignal TransductionTestingTherapeuticThyroid DiseasesThyroid Function TestsThyroid GlandThyroid HormonesThyroxineTissuesTransplantationWorkcell replacement therapycell typedirected differentiationembryonic stem cellgene networkgene regulatory networkhuman diseasehuman modelin uteroin vivoin vivo regenerationinduced pluripotent stem cellinsightmolecular phenotypemutantmutation correctionnoveloverexpressionpre-clinicalpreclinical developmentprogenitorreconstitutionregenerative cellregenerative therapysingle-cell RNA sequencingstem cell based approachstem cell technologystem cellssuccesstranscription factorvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The development of the thyroid gland from anterior endoderm is an essential step in development that allows for
the production of thyroid hormones around week 12 in utero in humans. Unfortunately, in about 1/4000 births
genetic mutations that affect this development pathway lead to congenital hypothyroidism requiring lifelong
thyroid hormone replacement therapy. Thus, a better understanding of thyroid follicular cell development could
lead to a process where genetic editing and cellular therapy could provide treatment for congenital
hypothyroidism (CH). Our work in this area has utilized a directed differentiation approach and has identified
bone morphogenic protein and fibroblast growth factor as key mediators of thyroid follicular cell lineage
development across species resulting in functional murine thyroid follicular cells that can rescue athyreotic mice.
In this proposal, we now turn our attention exclusively to human thyroid follicular cell development and propose
three Specific Aims that will allow for the pre-clinical development of functioning human thyroid follicular cells
derived from human induced pluripotent stem cells (iPSCs), In the first Aim we will utilize a novel lineage tracing
methodology to understand how developing human thyroid follicular acquire their cell fate and to ensure that the
process in iPSC parallels that in vivo. In the second Aim we will prove that the human thyroid follicular cells
derived from iPSCs are fully able to produce thyroid hormones in vitro and can be transplanted into
immunodeficient athyreotic mice to rescue their hypothyroidism. Finally, in the third Aim we will demonstrate pre-
clinically that derived iPSCs from a patient with CH can be genetically corrected and re-introduced via transplant
to function normally. Together completion of these Aims will provide key insight into the possibilities of iPSC
derived cellular therapy for the treatment of CH and enhance our understanding of the development endodermal-
derived tissues in humans.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.mce.2016.11.012
发表时间:
2017-04-15
期刊:
Molecular and cellular endocrinology
影响因子:
4.1
作者:
[Hollenberg AN, Choi J, Serra M, Kotton DN]
通讯作者:
Kotton DN
DOI:
10.3389/fendo.2021.666565
发表时间:
2021
期刊:
Frontiers in endocrinology
影响因子:
5.2
作者:
[Posabella A, Alber AB, Undeutsch HJ, Droeser RA, Hollenberg AN, Ikonomou L, Kotton DN]
通讯作者:
Kotton DN
Thyroid Hormone Signaling in Human Hepatocytes
-
批准号:10874207
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2023
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Hypothalamic regulation by thyroid hormone receptor phosphorylation
-
批准号:10717820
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Corepressor regulation of nuclear receptor action
-
批准号:10562608
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2022
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Hormone Signaling in Human Hepatocytes
-
批准号:9902423
-
项目类别:
-
资助金额:$68.27万
-
财政年份:2019
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Hormone Signaling in Human Hepatocytes
-
批准号:10087920
-
项目类别:
-
资助金额:$65.86万
-
财政年份:2019
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Hormone Signaling in Human Hepatocytes
-
批准号:10337213
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2019
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Corepressor regulation of nuclear receptor action
-
批准号:9701510
-
项目类别:
-
资助金额:$66.99万
-
财政年份:2018
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Follicular Cell Development in Mice and Humans
-
批准号:9697589
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2018
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Follicular Cell Signaling and Development in Humans
-
批准号:10435571
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2015
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Follicular Cell Development in Mice and Humans
-
批准号:9035478
-
项目类别:
-
资助金额:$39.66万
-
财政年份:2015
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Thyroid Follicular Cell Signaling and Development in Humans
-
批准号:10298043
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2015
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
New Targets of Thyroid Hormone Action
-
批准号:8900278
-
项目类别:
-
资助金额:$50.64万
-
财政年份:2013
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
New Targets of Thyroid Hormone Action
-
批准号:9090055
-
项目类别:
-
资助金额:$50.64万
-
财政年份:2013
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
New Targets of Thyroid Hormone Action
-
批准号:8735134
-
项目类别:
-
资助金额:$50.64万
-
财政年份:2013
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
New Targets of Thyroid Hormone Action
-
批准号:8630009
-
项目类别:
-
资助金额:$53.34万
-
财政年份:2013
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Defining the thyroid hormone receptor Cistrome in vivo
-
批准号:8299630
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2011
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Defining the thyroid hormone receptor Cistrome in vivo
-
批准号:8114945
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2011
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Negative regulation by thyroid hormone
-
批准号:8009199
-
项目类别:
-
资助金额:$5.09万
-
财政年份:2010
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Negative regulation by thyroid hormone
-
批准号:7585204
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2007
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
Negative regulation by thyroid hormone
-
批准号:7247441
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2007
-
负责人:ANTHONY N HOLLENBERG
-
依托单位:
海外基金